Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Dr Vikki Rand

Newcastle AuthorsTitleYearFull text
Dr Paul Sinclair
Dr Ruth Cranston
Prahlad Raninga
Joanna Cheng
Rebecca Hanna
et al.		Disruption to the FOXO-PRDM1 axis resulting from deletions of chromosome 6 in acute lymphoblastic leukaemia2023
Dr Carmela Ciardullo
Dr Katarzyna Szoltysek
Dr Peixun Zhou
Dr Elaine Willmore
Dr Amir Enshaei
et al.		Low BACH2 expression predicts adverse outcome in chronic lymphocytic leukaemia2022
Alex Newman
Dr Masood Zaka
Dr Peixun Zhou
Dr Amy Erhorn
Amy Barnard
et al.		Biallelic Inactivation of TP53 is Associated with an Increased Risk of Relapse in Paediatric B-Cell Non-Hodgkin Lymphoma(B-NHL)2019
Dr Peixun Zhou
Dr Alex Blain
Alex Newman
Dr Masood Zaka
Dr Ugo Offor
et al.		Sporadic and endemic Burkitt lymphoma have frequent FOXO1 mutations but distinct hotspots in the AKT recognition motif2019
Dr Peixun Zhou
Dr Amir Enshaei
Alex Newman
Dr Amy Erhorn
Amy Barnard
et al.		A genomic classification model enables risk stratification of paediatric endemic Burkitt lymphoma2018
Dr Peixun Zhou
Dr Amir Enshaei
Alex Newman
Dr Amy Erhorn
Amy Barnard
et al.		A Genomic Classification Model Enables Risk Stratification of Paediatric Endemic Burkitt Lymphona in Malawi2018
Alex Newman
Dr Masood Zaka
Dr Peixun Zhou
Dr Amy Erhorn
Dr Rachel Crossland
et al.		Biallelic inactivation of TP53 is associated with an increased risk of relapse in paediatric B-cell non-Hodgkin lymphoma (B-NHL)2018
Alex Newman
Dr Peixun Zhou
Dr Masood Zaka
Professor Christine Harrison
Dr Simon Bomken
et al.		Genomic landscape of adult and paediatric B-cell Non-Hodgkin lymphoma2018
Dr Masood Zaka
Dr Rachel Crossland
Amy Barnard
Sara Wilkinson
Dr Simon Bomken
et al.		Integrated analysis of the genomic and microRNA landscapes identifies dysregulated pathways associated with relapsed paediatric B-cell Non-Hodgkin lymphoma2018
Dr Peixun Zhou
Alex Newman
Filbert Adlar
Casey Broadbent
Dr Alison Blain
et al.		Investigation of FOXO1 mutations in paediatric endemic and sporadic Burkitt lymphoma2018
Dr Richard Noble
Dr Natalie Bell
Dr Helen Blair
Huw Thomas
Nicole Phillips
et al.		Inhibition of monocarboxyate transporter 1 by AZD3965 as a novel therapeutic approach for diffuse large B-cell lymphoma and burkitt lymphoma2017
Dr Carmela Ciardullo
Dr Elaine Willmore
Dr Amir Enshaei
Dr Peixun Zhou
Dr Vikki Rand
et al.		BACH2 and BCL6 Cooperatively Fuction as Tumour Suppressors in CLL2016
Dr Carmela Ciardullo
Dr Elaine Willmore
Dr Peixun Zhou
Dr Vikki Rand
Professor Christine Harrison
et al.		Impact of the apoptotic regulator DRAK2 in chronic lymphocytic leukemia2016
Dr Mark Wade
Dr Nicola Sunter
Dr Sarah Fordham
Anna Long
Dino Mašić
et al.		c-MYC is a radiosensitive locus in human breast cells2015
Katie Dormon
Elda Latif
Dr Matthew Bashton
Dr Deepali Pal
Dr Helen Blair
et al.		A Whole Genome In Vivo Crispr Screen in Primary ALL Predicts Leukaemic Relapse2015
123